Amsterdam’s VectorY Therapeutics closes one of Europe’s largest private biotech financings in 2023
Amsterdam-based VectorY Therapeutics, a biotech company, announced on Monday that it has secured €129M in a Series A round of funding co-led by EQT Life Sciences and the Forbion Growth Opportunities Fund.